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Abstract
Peptide/protein hormones could be stored as non-toxic amyloid-like structures in pituitary secretory granules. ACTH and b-
endorphin are two of the important peptide hormones that get co-stored in the pituitary secretory granules. Here, we study
molecular interactions between ACTH and b-endorphin and their colocalization in the form of amyloid aggregates.
Although ACTH is known to be a part of ACTH-b-endorphin aggregate, ACTH alone cannot aggregate into amyloid under
various plausible conditions. Using all atom molecular dynamics simulation we investigate the early molecular interaction
events in the ACTH-b-endorphin system, b-endorphin-only system and ACTH-only system. We find that b-endorphin and
ACTH formed an interacting unit, whereas negligible interactions were observed between ACTH molecules in ACTH-only
system. Our data suggest that ACTH is not only involved in interaction with b-endorphin but also enhances the stability of
mixed oligomers of the entire system.
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Introduction
Amyloids are highly ordered protein/peptide aggregates that
are associated with a number of human diseases including
Alzheimer’s and Parkinson’s [1]. Natively structured or unstruc-
tured peptides/proteins undergo structural transition to form
cross-b-sheet rich amyloids. This transition is known to happen
via partially folded intermediates and soluble oligomers [2].
Many proteins/peptides can form amyloids under certain
environmental conditions suggesting that amyloid formation is a
generic property of polypeptide chains [3]. Several studies in the
recent past have found that amyloids are also involved in several
native biological functions [4,5]. For example, amyloids of curli
protein help E. coli for surface attachment and colonization [6].
Amyloids of chaplins are involved in aerial hyphae and fruiting
body formation in filamentous fungi [7,8]. Moreover, yeast prions
[9,10] and HET-s amyloid in Podospora anserina [11] are also well-
studied examples of functional amyloids that are important for
survival of the respective host and not just related to prevalence in
diseased condition. The amyloid form of pmel17 in the
melanosome appears to be used as a template for melanin
synthesis and therefore protect melanocytes from reactive oxygen
and free radicals [12]. In addition, aggregation has also been
shown to be involved in secretory process of protein/peptide
hormones [13].
Protein secretion in secretory cells of eukaryotes is primarily of
two types: constitutive secretion and regulated secretion [14,15].
In constitutive secretion, the newly synthesized proteins are
secreted via vesicular trafficking immediately after exiting the
Golgi without any external stimulus. Whereas, in regulated
secretion, secretory proteins/peptides are stored for extended
periods of time in a highly concentrated form within membrane-
enclosed structures (secretory granules) in the cytoplasm [16,17].
The secretory granules (SG) primarily consist of condensed
aggregates of proteins/peptides [17,18]. Many secretory proteins
have been shown to form intermolecular aggregates at granule
relevant conditions in vitro, and protein aggregates were also
observed in vivo. These observations suggest that reversible
aggregation is the necessary step for condensing and sorting of
the secretory granule proteins (for review see; [17,18,19].
However, it was not clear whether the aggregated and concen-
trated proteins inside the granules are amorphous or contain any
specific structure. It has recently been suggested that protein/
peptides are stored as amyloid-like structures inside the secretory
granules of pituitary [13]. A large number of secretory protein/
peptide hormones formed non-toxic amyloids in vitro under
granule relevant conditions. Also evident were amyloid like
structures in the SG of hormones in AtT20 cells as well as rat
pituitary tissue. However, the studies also showed that some of the
peptide hormones such as ACTH and ghrelins do not form
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amyloids in presence of b-endorphin (b-end) and obestatin,
respectively [13]. ACTHs are also co-localized with b-end in the
secretory granules of AtT20 cells. This study supported the
hypothesis that heterotypic aggregation might be responsible for
concentrating and sorting of non-aggregating peptide/protein
hormone.
To understand the role of heterotypic aggregation between
ACTH and b-end for their storage in secretory granules, we have
performed experiments in silico, in vitro and in vivo and the results
are presented in this paper. Our results suggest that unlike b-end,
ACTH is neither able to change its conformation nor does it
aggregate into amyloids in vitro (for the amino acid sequences see
Table S1). Interestingly, ACTH and b-end co-localize in rat
pituitary tissue, consistent with previous study suggesting that
ACTH might require b-end as its aggregation partner [13]. To
delineate the molecular interactions and possible early events of
oligomerization of ACTH and b-end, we performed all atom
molecular dynamics (MD) simulations in explicit solvent. The data
suggest that ACTH is able to interact with b-end to form mixed
trimers similar to the b-end-only simulation. We also find that, in
presence of b-end, ACTH not only participates in oligomerization,
but also enhances the overall stability of the mixed trimer. In
contrast, significant intermolecular interactions were absent in
ACTH-only simulation, suggesting that ACTH requires b-end for
its conformational transition and aggregation in secretory
granules. Furthermore, we performed aggregation studies on
full-length b-end and N-terminal truncated b-end (b-end (6–31)) in
vitro; the data suggested that N-terminal residues play a role in b-
end aggregation as seen in our MD simulations.
Methods
In vitro aggregation of ACTH and b-end
Human ACTH (hACTH), human b-end (hb-end) and b-end
(6–31) were purchased from BACHEM. Peptides were dissolved
either in 5% D-mannitol, pH 5.5 or in PBS, 0.01% sodium azide
at a concentration of 2 mg/ml in 1.5 ml eppendorf tubes. The
aggregation study in presence of different concentrations of low
molecular weight (LMW) heparin was initiated by mixing 10 mM
of heparin solutions and 1 mM of ACTH solution in 5% D-
mannitol. The eppendorf tubes containing hormone solutions
were placed into an Echo Therm model RT11 rotating mixture
(Torrey Pines Scientific) with a speed corresponding 50 r.p.m.
inside a 37uC incubator. The fibril formation was monitored by
circular dichroism (CD) and ThT binding studies. At the end of
aggregation, electron microscopy (EM)/atomic force microscopy
(AFM) studies were performed for morphological characteriza-
tion. Three independent experiments were performed for each
sample.
Circular dichroism spectroscopy (CD)
10 ml of hormone solutions were diluted in 5% D-mannitol to
200 ml. The peptide solutions were placed into a 0.1 cm path-
length quartz cell (Hellma, Forest Hills, NY). Spectra were
acquired using a JASCO 810 instrument. All measurements were
done at 25uC. Spectra were generally recorded over the
wavelength range of 198–260 nm. For better elucidation of the
differences in secondary structure, the CD data of full-length b-
end in presence of heparin at day 4 is represented from 260 nm to
207 nm. Three independent experiments were performed with
each sample. Raw data were processed by smoothing and
subtraction of buffer spectra, according to the manufacturer’s
instructions.
Thioflavin T (ThT) binding
A1 0ml aliquot of peptide sample was diluted to 500 ml5 %D -
mannitol containing 0.01% (w/v) sodium azide. The solution was
mixed with 2 ml of 1 mM ThT prepared in the same solution.
Fluorescence was measured immediately after addition of ThT
using 10 mm rectangular quartz micro-cuvette. The fluorescence
was measured on a spectrofluorimeter with excitation at 450 nm
and emission at 482 nm or between 460–500 nm. The fluores-
cence intensity at 482 nm was plotted in the graph. Three
independent experiments were performed for each sample.
Electron microscopy (EM)
5 ml aliquot of peptide samples were diluted into 50 ml of water
to a peptide concentration of ,40 mM, spotted on a glow-
discharged, carbon-coated Formvar copper grid (Electron Micros-
copy Sciences, Fort Washington, PA), incubated for 5 min,
washed with distilled water, and then stained with 1% (w/v)
aqueous uranyl formate solution. Uranyl formate solutions were
filtered through 0.2 mm sterile syringe filters (Corning) before use.
EM analysis was performed using a FEI Tecnai G2 12 electron
microscope at 120 KV with nominal magnification between
26,000 to 60,000. Images were recorded digitally by using the
SIS Megaview III imaging system. At least two independent
experiments were carried out for each sample.
Atomic force microscopy (AFM)
For AFM, 2 mg/ml peptide solutions were diluted into 100 fold
by water and diluted sample was spotted on a freshly cleaved mica
sheet followed by washing with water. The mica was dried under
vacuum desiccators. The imaging was done in tapping mode
under a silicon nitride AFM cantilever using Veeco Nanoscope IV
multimode AFM. At least five different areas of two independent
samples were scanned with a scan rate of 1.0 Hz.
2,2,2-Trifluoroethanol (TFE) titration of ACTH and b-end
TFE titration of ACTH and b-end was carried out to probe the
intrinsic ability of these peptides to form ordered structure. To do
so, ACTH and b-end were dissolved at a concentration of 2 mg/
ml in phosphate buffered saline (pH 7.4). The peptide solutions
and TFE were mixed such that the resulting concentration of
ACTH and b-end is of 45 mM and TFE was varied from 0 to 80%
(V/V). The resulting solution was used immediately for CD
measurement as described before.
Immunohistochemistry
Adult, male, Wistar rats weighing 220–250 g were housed
under standard environmental condition (light between 600 and
1800 h, temperature 2261uC, chow and water ad libitum). All the
experimental procedures were approved by the Institutional
Animal Ethics Committee (Approval number 92/1999/CPCSEA),
Department of Pharmaceutical Sciences, Nagpur University,
Nagpur, India. Animals were anaesthetized with sodium pento-
barbital and perfused transcardially with 20 ml phosphate
buffered saline (PBS, 0.01 M, pH 7.4) followed by 150 ml 4%
paraformaldehyde in phosphate buffer (0.1 M, pH 7.4). The
pituitary glands were dissected out and postfixed in the same
fixative overnight at 4uC. The pituitary glands were cryoprotected
in 25% sucrose solution in PBS overnight at 4uC, frozen in
mounting media (Tissue-Tek, Torrance, CA), sectioned on a
cryostat (CM 1850, Leica) at 12 mm thickness in coronal plane and
collected in PBS to get four series of alternate sections. Sections
were stored at 220uC in freezing solution until processed further.
Sections were rinsed in PBS and treated with 0.5% Triton X-100
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horse serum in PBS for 30 min and incubated overnight at 4uCi n
a mixture of anti-rabbit ACTH polyclonal antiserum (National
Hormone Pituitary Program, NIH, USA) diluted 1:2000 and rat
monoclonal b-end antibody (Cat# ab54205, Abcam, USA)
diluted 1:2000 in antibody diluent. Sections were rinsed in PBS
and incubated in a mixture of DyLight488-conjugated goat anti-
rabbit IgG (Jackson Immunoresearch, USA, 1:250) and Cy3-
conjugated donkey anti-rat IgG (Jackson Immonoresearch, 1:250)
for 4 h at room temperature. Sections were rinsed in PBS followed
by Tris (pH 7.6) and mounted with Vectashield mounting medium
containing DAPI (Vector Laboratories, USA). Sections were
observed under Olympus BX51 epifluorescence microscope using
a dual filter set for DyLight 488 and Cy3 (Cy3, excitation 540–
590 nm and emission 600–660 nm; DyLight, excitation 490–
505 nm and emission 515–525 nm).
Images of ACTH and b-end immunoreactivities were captured
on a Confocal Laser Scanning microscope (TCS SP5, Leica
Microsystems CMS GmbH, Germany) using the following laser
excitation lines: DyLight488 493 nm, and Cy3 543 nm. These
filter combinations resulted in negligible cross talk between
individual fluorochrome signals. All imaging was done in
sequential scan mode to exclude cross-bleeding between different
channels. Images were adjusted for contrast and brightness using
Adobe Photoshop CS4.
MD Simulation
All atom MD simulation is proven to be an important tool to
understand the protein folding and protein aggregation in silico
[20,21,22,23,24]. We performed all atom MD simulations to study
the inter-peptide interactions between ACTH and b-end. We used
the MD software package NAMD [25] and visualization tool
VMD [26] in order to carry out the experimental procedures. The
initial structures of ACTH and b-end for the simulation were
constructed using the peptide builder tool in the molecular
modeling and bioinformatics software package VEGA ZZ [27].
The coordinates were then subjected to intensive energy
minimization using the conjugate-gradient algorithm for 15,000
steps. We performed MD simulation on the ACTH and b-end
monomers in order to characterize structural fluctuations and to
obtain a reliable starting structure for our simulation. Three sets of
simulations were performed for 20 ns, each involving the study of
interactions between four peptides placed in a solvent box: i) two
molecules each of ACTH and b-end, ii) four molecules of ACTH,
Figure 1. Structural transition and amyloid aggregation of ACTH and b-end. A) 2 mg/ml ACTH in presence of different concentrations of
heparin were incubated for two months. Insignificant structural changes are observed at day 0 (top panel, left) and after two months (top panel,
right) of incubation at 37uC with slight rotation at pH 5.5, suggesting that ACTH is highly soluble and non-amyloidogenic. Different symbols
represent concentrations of heparin in mM. Similar experiments were also performed with various ACTH and heparin concentration ratios for two
months (lower panel). No significant structural transformations were observed at day 0 (left, lower panel) and after two months of incubation (right,
lower panel). B) ThT binding of ACTH and b-end samples incubated for two weeks either in PBS or in 5% D-mannitol at 37uC with slight rotation. Only
b-end was able to bind ThT significantly, both in PBS and in 5% D-mannitol, 0.4 M heparin suggesting b-end is amyloidogenic. C) Conformational
transition of 2 mg/ml ACTH (left) and b-end (right) incubated in PBS, pH 7.4, 0.01% sodium azide for two weeks. ACTH did not show significant
conformational transition whereas b-end showed random coil to b-sheet transition after two weeks of incubation. D) TFE induced structural transition
of ACTH and b-end. ACTH is unable to change its conformation even in presence of 80% TFE. Whereas, b-end changes its conformation from random
coil to helix in presence of TFE concentration (.20% TFE v/v). Each symbol represents different concentrations of TFE (v/v).
doi:10.1371/journal.pone.0031924.g001
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used for all simulation systems. The initial positions of the peptides
within the simulation box were such that the orientations were
random and the closest point between any two peptides in the
simulation box was not less than 15 A ˚. The system was first energy
minimized using conjugate gradient algorithm for 15,000 steps at
an absolute zero temperature. The system was then linearly heated
from 0 K to 310 K using temperature rescaling. Once the slow
heating procedure was performed, the system was then equili-
brated at 310 K for another 300 ps using reassigned velocities at
every step. After the energy-minimization, linear heating, and
equilibration steps, the system was used for the ‘‘production run’’
or ‘‘dynamic run’’ of 20 ns. In each of the 3 simulations, we used
an integration time step of 2 fs. The van der Waals interaction
cutoff used was 9 A ˚ and the electrostatic interaction cutoff was
12 A ˚. The density of the water box was adjusted using NPT
equilibration to ,0.99 g/cm
3. The size of the water box was
dependant on the initial orientation and conformation of the
peptides. The ACTH, b-end and ACTH-b-end combined systems
were solvated in a simulation box of volume 1749763 A ˚ 3,
1063315 A ˚ 3 and 1394820 A ˚ 3 respectively.
Results
ACTH is natively unstructured peptide, non-aggregating
and non-amyloidogenic
Previous studies of hACTH, rACTH and pACTH have
suggested that none of the ACTHs self aggregated into amyloid-
like fibrils in vitro [13]. However, ACTH co-aggregated with b-end
into amyloid-like structure. Detailed studies were carried out to
illustrate the self-aggregating behavior of hACTH at varying
concentrations and also in presence of varying amounts of GAGs
(heparin) in 5% D-mannitol, pH 5.5, 0.01% sodium azide
(Figures 1A and B). Amyloid formations were monitored by CD,
ThT binding and EM. CD studies indicated that ACTH did not
undergo any structural transition even after two months of
incubation (Figure 1A) under different conditions. Moreover,
negligible ThT fluorescence of the two months incubated samples
Figure 2. Aggregation and colocalization of ACTH and b-end. A) Fluorescence photomicrographs of the anterior (A–C) and intermediate (D–F)
lobes of the pituitary gland showing ACTH (A, D), b-end (B, E), and ACTH-b-end colocalized (C, F) cells. Note that presence of several double-labeled
cells (arrows) in anterior as well as intermediate lobes. Scale bar=50 mm. B) EM images of ACTH and b-end samples incubated for 14 days. The
aggregations of the hormones were followed at 37uC at a concentration of 2 mg/ml in the presence of 0.4 mM LMW heparin in 5% D-mannitol
(pH 5.5) and PBS under slight agitation. TEM of negative stained samples was performed. Scale bars, 500 nm.
doi:10.1371/journal.pone.0031924.g002
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EM suggest that ACTH is non-amyloidogenic (Figure 2B). We also
examined whether a buffer with high salt concentration such as
PBS might modulate the aggregation and amyloid formation of
ACTH and b-end. The aggregation data in PBS, pH 7.4, 0.01%
sodium azide suggested that b-end formed amyloid-like fibrils in
PBS after two weeks of incubation (Figures 1B, 1C and 2B) as it
showed random coil (RC) to b-sheet structural transition in CD,
high ThT binding and appearance of fibrillar morphology under
EM; whereas ACTH did not show any amyloid-like fibrils in
identical experimental conditions. A decrease in CD signal at
wavelength ,198 nm was observed for ACTH after two weeks of
incubation in PBS, indicating subtle change in secondary
structure. However, CD signal in the wavelength range of 208–
222 was mostly unchanged during incubation suggesting that
major secondary structural transition was absent. To further
evaluate whether ACTH has any intrinsic structural propensity,
we initiated the experiment with TFE. TFE is known to destabilize
hydrophobic interactions within the polypeptide chain and
stabilizes local hydrogen bonds between residues close in the
amino acid sequence [28]. It has long been suggested that TFE
could induce helices in peptide/proteins in solution. To study the
effect of TFE on secondary structures of ACTH and b-end, we
performed CD experiments of 25 mM each of ACTH and b-end in
PBS, pH 7.4 with increasing concentrations of TFE. The data
suggested that ACTH is unable to change to any helical structure
up to 80% of TFE concentration (v/v). Interestingly, b-end
showed increased helicity in a TFE concentration dependent
manner (Figure 1D). These results further suggest that ACTH
does not possess any intrinsic tendency for structural change and/
or aggregation by its own, but might change its structure in
presence of b-end.
ACTH and b-end are colocalized in vivo
Since ACTH and b-end are processed from the same
prohormone (pro-opiomelanocortin) and secreted together via
regulated secretory pathway [29], we hypothesized that ACTH
might need the amyloid-forming b-end as an aggregation partner
for its storage in secretory granules. The previous in vitro and
immunofluorescence studies with AtT20 cells are consistent with
this hypothesis [13]. Double labelling immunofluorescence study
was performed using rat pituitary tissue to explore the anatomical
substrates in the anterior pituitary where ACTH and b-end
colocalize. We observed that most of the ACTHs are co-localized
with b-end both in anterior and intermediate lobes of pituitary
gland (Figure 2A).
Figure 3. MD simulation of ACTH system. A) Snapshots at the left-hand side indicating initial state (t=0 ns) and at the right-hand side indicating
final state (t=20 ns) of the simulation. B) Plot of distances between center of masses (Dij) of peptides within the ACTH simulation against time
showing large interpeptide distances during simulation. C) Contact map at t=20 ns snapshot showing residues in contact. Negligible interpeptide
contacts are observed suggesting that peptides are not self-assembling in silico.
doi:10.1371/journal.pone.0031924.g003
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To understand the interpeptide interactions of ACTH in silico,
all atom MD simulation was performed. Snapshots of initial and
final configurations of the system are shown in Figure 3A whereas
the detailed time progression is shown in Figure S1. From the
radius of gyration (Rg) and root mean square deviation (RMSD)
(Figures S2A and S2B) data, we observe structural fluctuations of
the peptides for the entire duration of the simulation. The
snapshots as well as the inter-peptide distances (Dij) plot
(Figure 3B) indicate that major intermolecular contacts between
ACTHs were absent during the 20 ns simulation. The distance
between center of masses of the ACTH peptides are gradually
increasing during the simulation period indicating that ACTH
molecules have very little tendency to interact. Although subtle
decrease in interpeptide distance between ACTH C and ACTH
D were observed, distance between these two peptides remains
,20 A ˚ at the end of 20 ns simulation (Figure 3B). Consistent
with interpeptide distances, significant hydrogen-bonding ten-
dency was also absent. There was intermittent hydrogen bonding
tendency observed for the initial part of the simulation that
disappeared at the later phase, suggesting negligible tendency for
inter-peptide hydrogen bonding among ACTHs in silico.T h i si s
further supported by the contact map data shown in Figure 3C.
The sparse contacts seen between peptides C and D at the final
time step are transient in nature. The structural transition during
simulation has also suggested that most of the amino acid residues
of ACTH are reluctant to undergo any major secondary
structural transition in the entire duration of the simulation,
Figure 4. MD simulation of b-end system. All-atom MD simulation for the duration of 20 ns was performed in explicit solvent using four b-end.
A) Snapshots indicating the initial (left) and final (right) states of the b-end system. B) Plot of distances between center of masses (Dij) of peptides
within the b-end simulation against time. C) Contact map showing various residues in contact between peptides at t=20 ns. Significant contacts are
observed between amino acid residues in b-end A, b-end B and b-end D. D) A schematic depicting the various h-bonds observed between the
peptides during the b-end simulation. The schematic showing C-terminus of b-end D is in contact with N-terminus of b-end A whereas C-terminus of
b-end B is in contact with C-terminus b-end A. A salt bridge between E31 of b-end A and K28 of b-end B is represented by red dotted line.
doi:10.1371/journal.pone.0031924.g004
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consistent with our in vitro experimental studies.
Self-association and structural transition of b-end in silico
Our in vitro studies suggested that b-end is able to undergo
secondary structural transition from random coil to helix in
presence of TFE and also shows amyloid formation in solution
(Figures 1 and 2). To further understand the nature of the
interaction, we performed in silico study using four b-end in a
simulation box similar to the ACTH. The snapshots of initial and
final configurations, shown in Figure 4A, indicate that three out of
four b-end molecules interact in an intermolecular manner to form
a trimeric assembly within the simulation box. The detailed
progression of the assembly is shown in Figure S3. Rg and RMSD
data (Figures S4A and S4B) for b-end show negligible fluctuation
indicating higher stability, compared to that observed in ACTH.
The separation of fourth b-end molecule from the trimer occurs at
,10 nsofsimulation(FigureS3).Whenthedistancebetweencenter
of masses of the b-end molecules were plotted against time
(Figure 4B), there was a marked decrease in interpeptide distance
observed for b-end A and b-end B (Dij AB), b-end A and b-end D
(Dij AD). Similar trendsarealso observed tosomeextent with b-end
B and b-end D. In contrast, an increase in separation was observed
between b-end C and the trimeric assembly. The contact map at
t=20 ns suggests that significant interpeptide contacts have
devoloped between b-ends A/B, A/D and B/D (Figure 4C),
whereas no contacts were observed between b-end C and any other
b-ends. The secondary structural transition during the simulation
showed an increase in helical propensity in the b-end D (Figure
S4C) whereas, signatures of b-strand propensity were only observed
inb-endAofthetrimericassembly.Thedetailedexaminationofthe
hydrogen bonding (h-bonding) pattern within the trimer (depicted
schematicallyinFigure4D)suggeststhatC-terminusofb-endDwas
interacting with N-terminus of b-end A, whereas C-terminus of b-
end A was interacting with C-terminus of b-end B. Only those
hydrogen bonds, which were observed for more than 50% of the
duration of the simulation, were considered for the schematic
depiction. These interactions (Table S2) are mainly mediated by
intermolecular h-bonding either through mainchain-mainchain or
mainchain-sidechain or sidechain-sidechain interactions. Further-
more, a stable salt bridge was observed between Glu
31 of b-end A
and Lys
28 of b-end B that existed for most of the simulation time.
Figure 5. Snapshots at various time steps of ACTH-b-end simulation system showing hetero-oligomerization. The hetero-trimer
consisting of two b-end and one ACTH is stable up to end of 20 ns simulation. b-end A, b-end B, ACTH C and ACTH D are represented by blue, yellow,
green and purple color, respectively.
doi:10.1371/journal.pone.0031924.g005
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The in vitro and in vivo data suggested that ACTH and b-end co-
aggregate to form amyloids, and co-localize in AtT20 cells and in
rat pituitary tissues. However, the nature of interactions between
these two peptides is not yet clear. To understand the early stages
of coaggregation between ACTH and b-end, we performed MD
simulation with two ACTH and two b-end in explicit solvent. As
seen in the snapshots of the configurations, two b-end molecules
get associated with one ACTH molecule to form a mixed trimeric
assembly (Figures 5 and 6A). Rg and RMSD (Figures S5A and
S5B) indicate that the system has approached a stable steady state
towards the end of the simulation. Interestingly, ACTH C, which
is not a part of the trimeric assembly, shows significantly higher
fluctuations compared to the other peptides in the simulation box.
The distance (Dij) vs time plot (Figure 6B) shows the separation of
ACTH C from the peptides within the trimeric assembly and the
proximity of the b-end A, b-end B and ACTH D. In order to
assess the stability of various interactions, we analyzed inter-
peptide contacts at various time steps of the simulation (Figures 6C
and 6D). The data suggests that the approximate regions of Leu
14-
Asn
20 of the two b-end molecules (A and B) are in contact for a
prolonged duration of the simulation (Figure 6C). Additional
contacts have also been observed between the residues near the C-
Terminus (Ile
20-Ala
26)o fb-end A and those at the N-terminus
Figure 6. MD simulation of ACTH-b-end system. All-atom MD simulation for the duration of 20 ns was performed in explicit solvent using two
ACTH and two b-end. A) Snapshots at the left-hand side indicating the initial configuration (t=0 ns) and at right-hand side indicating the final
configuration (t=20 ns). B) Plot of distances between center of masses (Dij) of peptides against time indicating close proximity of peptides A, B and
D. C) Time progression of contact regions between b-end A and b-end B. At any given time, the regions indicated by red lines of b-end B is in contact
with regions indicated by blue lines of b-end A. Similarly, the regions indicated by black lines of b-end B is in contact with regions indicated by green
lines of b-end A. The first contact pair (red and blue) is seen for the entire duration of the simulation whereas the second contact pair (black and
green) appears only towards end of the simulation. D) Time progression of contact regions between ACTH D and b-end B. At any given time, the
regions indicated by red lines of ACTH D is in contact with regions indicated by blue lines of b-end B. Similarly, the regions indicated by black lines of
b-end B is in contact with regions indicated by green lines of ACTH D. The first contact pair (red and blue) is seen for the initial part of the simulation
whereas the second contact pair (green and black) appears only towards end of the simulation. Additional contacts are also observed for certain
duration between the region of b-end B (aqua line) and ACTH D (pink line).
doi:10.1371/journal.pone.0031924.g006
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3-Ser
7)o fb-end B, towards the end of the simulation. This
observation indicates that the orientation of the two b-end
molecules that were initially at random, assumes an anti-parallel
orientation towards the later part of the simulation. The contact
progression between ACTH D and b-end B also shows similar
stable contacts throughout the simulation (Figure 6D). Initial





35) of ACTH D. However, at later time steps,
newer contacts were observed between the regions of (Lys
19-Asn
25)
of b-end B and the region (Phe
7-Lys
15) of the ACTH D molecules
(Figure 6D). The contact map at t=20 ns (Figure 7A) shows that
significant contacts exist between b-end A and B, and between b-
end B and ACTH D. Occasional sparse contacts were also
observed between ACTH D and b-end A. We also performed a
detailed analysis of the h-bonding pattern between the peptides of
the trimeric assembly. Those hydrogen bonds that are present for
more than 50% of the total duration of the simulation (Table S3)
are considered as ‘‘stable’’ hydrogen bonds, and are schematically
depicted in Figure 7B. As shown in the figure, the b-end B is
sandwiched between b-end A and ACTH D through h-bonding.
The middle part of the b-end B is interacting with middle part of
the b-end A in an anti-parallel fashion, while N- and C- termini of
b-end B is interacting with N- and C- termini of the ACTH D in a
parallel fashion. Importantly, the numbers of the stable hydrogen
bonds are significantly more in this mixed system compared to the
b-end-only system described earlier, suggesting that the mixed
system is more stable. The plot of secondary structure progression
of each of the peptides (Figure S5C) suggest an intermittent
tendency to adopt the b-strand conformation at the region of
Val
15-Phe
18 of both the interacting b-end (A and B). Additionally,
some occasional b-strand tendency is observed in the regions Phe
4-
Ser
6 of the b-end B that is in tight contact with ACTH D. The
regions of b-end A and B showing b-strand tendency during the
course of the simulation also coincide with the b-aggregation
region, predicted by the TANGO algorithm [30]. Interestingly
ACTH D, which is part of the trimer, also showed some b-strand
tendency compared to the non-interacting ACTH C. The region
between residues Pro
24-Asp
29 of ACTH D shows the maximum b-
strand tendency and this is correspondingly the region, which is in
contact with b-end B.
N-terminal deletion of b-end affects the aggregation and
amyloid formation tendency in b-end
From our in silico simulation study of b-end and b-end/ACTH
system, we observed that many intermolecular interactions (h-
bonds and salt bridges; see Table S2 and S3) are responsible for
the early oligomerization event of these peptide self-assemblies.
For example, the Figure 4 shows that N-terminal Gly
2-Thr
6 amino
acid residues of b-end A are interacting with C-terminal Tyr
27-
Lys
29 amino acid residues of b-end D. To validate these findings,
we performed in vitro aggregation experiments of full-length b-end
and N-terminally truncated b-end (b-end (6–31) using CD, ThT,
EM and AFM. In our CD studies, we observed that both b-end
and b-end (6–31) showed mostly unstructured nature during one
week of incubation in 5% d-mannitol. However, in presence of
LMW heparin, b-end showed mostly a-helical conformation at
day 0 and transformed to b-sheet at day 4 (Figure 8A); while b-end
(6–31) showed mixture of random coil and helix at day 0, which
transformed to a predominantly a-helical conformation at day 4.
The data suggest a retardation of conformational transition to b-
sheet in b-end (6–31). The ThT fluorescence study of one week
incubated samples in presence of heparin showed less ThT
binding of b-end (6–31) compared to full-length b-end (Figure 8B).
The EM data (Figure 8C) of 7 days incubated samples showed that
numerous amyloid-like fibrils were formed by b-end, whereas very
thin and fewer fibrils were formed by b-end (6–31). In the absence
of heparin, both full-length b-end and b-end (6–31) did not show
any amyloid fibril formation, rather only small oligomers were
observed. AFM study of 7 days incubated sample of b-end and b-
end (6–31) also showed similar results (Figure 8D). The combined
data of CD, morphological study by EM, AFM and ThT
fluorescence suggest that truncation of 1–5 amino acid residues
Figure 7. Analysis of the interpeptide interactions in ACTH-b-end system. A) Contact map showing various residues in contact within the
ACTH-b-end simulation box at t=20 ns. B) Schematic representation of the stable hydrogen bonds observed between the peptides during the
simulation.
doi:10.1371/journal.pone.0031924.g007
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formation compared to full-length b-end.
Discussion
It was suggested that co-aggregation might be an essential
mechanism for nonaggregating peptide/proteins to be secreted via
regulated secretory pathways [13,31]. Previous in vitro studies using
exocrine enzymes that are stored in secretory granules have
suggested that many exocrine enzymes are able to aggregate under
granule-relevant conditions in vitro. However, amylase, an exocrine
enzyme, does not show homotypic aggregation under similar
conditions [31,32]. Interestingly, this enzyme aggregates in
presence of exocrine granular content, suggesting that heterotypic
Figure 8. Effect of N-terminal deletion on b-end aggregation. A) CD spectra of full-length b-end and b-end (6–31) at 2 mg/ml concentration in
5% D-mannitol, 0.01% sodium azide, pH 5.5 in presence and absence of 400 mM of LMW heparin. In the absence of heparin, both peptides remain
mostly unstructured up to one week of incubation at 37uC. In presence of heparin, the full-length b-end showing structural transition from a-helix at
d0 to mostly b-sheet at d4; while the b-end (6–31), which was in a mixed conformation of random coil and helix at d0, showing mostly a-helical
conformation at d4. Both peptides show mostly b-sheet conformation at d7. (B) The ThT fluorescence study of one week incubated sample in
presence of heparin showing less ThT binding of b-end (6–31) compared to full-length b-end. C) EM studies of 7 days incubated samples showing
numerous amyloid-like fibrils for full-length b-end and fewer fibrils for b-end (6–31) in presence of heparin. Any amyloid-like fibrils are not observed in
absence of heparin for both the peptides. D) AFM images of the full-length b-end and b-end (6–31) in presence and absence of heparin after a 7-day
incubation showing more number of fibrils in case of the full length b-end sample as compared to the b-end (6–31) sample. Scale bars are of 500 nm.
doi:10.1371/journal.pone.0031924.g008
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sorting of this enzyme in the secretory granules. The previous
studies have suggested that many peptide hormones such as
ACTHs (rACTH, pACTH and hACTH) and ghrelins do not
aggregate to form amyloids in vitro [13]. However, they aggregate
into amyloids in presence of their appropriate partner peptide
further suggesting that heterotypic aggregation might also be
responsible for their secretory granule formation in endocrine
cells.
In our study, ACTH did not aggregate either with varying
peptide/heparin ratio or in PBS even after two months of
incubation. This clearly indicates that ACTH is a highly soluble
peptide hormone and is incapable for aggregation and amyloid
formation. In contrast, b-end formed amyloids both in presence of
heparin (in D-mannitol) and in PBS. The TFE titration results
indicated that ACTH is also incapable of undergoing structural
transition even in presence of 80% TFE (v/v) whereas b-end
showed helical structure when titrated with varying concentration
of TFE. All these studies clearly suggest that ACTH might require
aggregation partner for its structural transition and amyloid
formation. This suggestion is further strengthened by the fact that
ACTH and b-end are largely colocalized in the pituitary cells [33].
Using alternate sections, concomitant storage of ACTH and b-end
immunoreactivity has been shown in the secretory granules of
anterior pituitary [34]. We observed that in the anterior and
intermediate lobes of the pituitary, ACTH and b-end are present
in the same cells.
In conjunction with our in vitro and in vivo data, MD simulation
studies of the three systems (ACTH+b-end, ACTH-only, and b-
end-only) also clearly show that ACTH cannot undergo
homotypic association; they rather show a higher tendency to
associate with b-end suggesting a heterotypic mechanism. The
ACTH-b-end mixed trimeric system showed more number of
interpetide contacts as compared to the trimer of the b-end-only
system suggesting that the former is the more stable system among
the two. This is further supported by the interpeptide contacts
observed during the 20 ns simulation time. Our data also indicates
that hydrophobic contacts might initiate both trimer and mixed
trimer formation. As seen in the case of b-end A and b-end B of
the mixed trimer, the region between the residues Leu
14-Lys
19 of
b-end A and B, which is a part of the most hydrophobic region
calculated by the Kyte Doolittle hydrophobicity scale [35], is
involved in forming stable contacts. ACTH molecules on the other
hand are lacking such a hydrophobic region, which might be
needed for self-aggregation, as observed in case of b-end. The
observation of more number of stable h-bonds in the mixed trimer
system, when compared to the b-end-only trimer, suggest that
ACTH increases the overall stability of the mixed trimer system.
This type of heterotypic assembly, on one hand, might be
favorable for ACTH to get packaged and stored; on the other
hand, also advantageous for b-end as ACTH increases the number
of stable h-bonds within the aggregate. The results suggest that the
interaction between the peptides in the ACTH-b-end system
might help to decrease the fluctuations, by providing an additional
degree of stability to the system compared to b-end-only system.
Interestingly, ACTH interacting with b-end showed some
secondary structural transition suggesting that b-end is absolutely
required for this structural transition. The previous in vitro data
have also suggested that tryptophan residue in ACTH in the
ACTH-b-end aggregates showed a blue shift in lmax compared to
the monomeric peptides, suggesting a change in microenviron-
ment [13] during aggregation.
Conclusion
Cross-seeding and hetero-aggregation are implicated in many
human diseases and peptide hormone storage in secretory granules
[13,31,36,37]. Here, we attempted to understand coaggregation of
ACTH-b-end using a wide variety of experimental and computa-
tional approaches. Our evidences strengthen the hypothesis that
ACTH peptide does not have the ability to form aggregated
structures; it needs the presence of b-end or similar interacting
partner to get aggregated in vitro and in silico. While ACTH certainly
gets benefited in the coaggregation with the b-end, it could also be a
preferred mechanism for b-end to be condensed and packaged into
secretory granules in a more stable manner. It is important to note
that thenumber of peptides used inthe simulation and the timescale
of the simulation is limited, thereby the simulation does not access
the timescale required for fibrillization. It is also possible that both
b-end and ACTH/b-end system require equimolar amount of
heparin(inaccordancetoinvitrostudy[13])inthesimulationboxfor
significant structural transition of the peptides into b-sheet structure
in silico. However, our simulations were aimed at studying the
tendency of the peptides to form inter-peptide contacts at early
stages of oligomerization, which might later initiate the secondary
structure transition from random coil to b-strand as well as amyloid-
like fibril formation. The delayed in vitro aggregation kinetics of
truncatedb-end(6–31)suggestthattheN-terminalresiduesofb-end
play an important role for its aggregation and amyloid formation,
which is consistent with our in silico findings.
Our data thus not only provide possible regions for inter-peptide
association and nature of the interactions but also helps to
understand the mechanism of secretory granule biogenesis by
ACTH and b-end.
Supporting Information
Figure S1 Snapshots showing time progression of the
ACTH simulation. Significant intermolecular association was
not observed. However, weak interactions between ACTH C and
ACTH D are evident at the end of 20 ns simulation. ACTH A, B,
C and D are represented by blue, red, purple and green color,
respectively.
(TIF)
Figure S2 Structural fluctuations and secondary struc-
ture progression of ACTH system. A) Time progression of
the radius of gyration (Rg) of individual peptides within the ACTH
system showing higher degree of fluctuation compared to ACTH-
b-end system (see Figure S5). B) The fluctuation observed in the
RMSD Vs time plot is also consistent with radius of gyration. C)
Secondary structure progression of amino acid residues (N-
terminus (top) to C-terminus (bottom)) of all peptides during the
simulation. Only ACTH A and ACTH C showed some secondary
structural transition from random coil to helix at certain regions.
Other two ACTHs failed to show any secondary structural
transition. White, green, blue, pink, yellow colors indicate random
coil, turn, p-helices, a-helices, b-strand, respectively.
(TIF)
Figure S3 Snapshots at various time steps of b-end
simulation system showing oligomerization of b-end.
One of the b-end was separated out from the other three b-end
that form trimeric assembly, which is stable up to 20 ns. b-end A,
B, C and D are represented by blue, red, purple and green color,
respectively.
(TIF)
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PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e31924Figure S4 Structural fluctuations and secondary struc-
ture progression of b-end system. A) Time progression of the
radius of gyration (Rg) of individual peptides within the b-end
system indicating the system attains stability towards the end of
simulation. B) The RMSD Vs time plot of all peptides within the b-
end system indicating the system has approached a steady state. C)
Secondary structure progression of amino acid residues (N-terminus
(top) to C-terminus (bottom)) of all peptides during the simulation.
Only b-end C and b-end D showed some secondary structural
transitionfromrandomcoiltohelixatcertainregions.White,green,
blue, pink, yellow colors indicate random coil, turn, p-helices, a-
helices, b-strand, respectively. Occasional appearances of b-strand
are seen in few residues of b-end A whereas b-end B failed to show
any secondary structure transition during simulation.
(TIF)
Figure S5 Structural fluctuations and secondary struc-
ture progression of ACTH-b-end system. A) Time progres-
sion of the radius of gyration of individual peptides within the
ACTH-b-end system indicating the system attains stability towards
the end of simulation. B) The RMSD Vs time plot of all peptides
within the ACTH-b-end system showing that peptides within
the trimeric assembly attains steady state towards the end of
simulation. C) Secondary structure progression of amino acid
residues of all peptides (N-terminus (top) to C-terminus (bottom))
during the simulation. b-end A showed some secondary structural
transition from random coil to helix at certain regions. Occasional
appearances of b-strands are seen in few residues of b-end B and
ACTH D both of which interact with each other to form a mixed
trimer. White, green, blue, pink, yellow colors indicate random
coil, turn, p-helices, a-helices, b-strand, respectively.
(TIF)
Table S1 Amino acid sequences of hACTH and hb-end.
(DOC)
Table S2 Major intermolecular interactions in b-end
simulation.
(DOC)
Table S3 Major interactions between ACTH and b-end.
(DOC)
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